Latest Headlines

  1. Eli Lilly's Foundayo™ Approved By FDA, Introducing A New Era Of Needle-Free GLP-1 Therapy 4/1/2026

    Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect® with free home delivery, starting at $25 per month with commercial coverage and $149 for self-pay

  2. ROIS CDMO Closes On The Acquisition Of US Injectable Manufacturing Facility 4/1/2026

    ROIS, the CDMO arm of ROVI and a leader in injectable manufacturing, today announces closing the acquisition of a state-of-the-art injectable drug product manufacturing and packaging site in Phoenix, Arizona (USA) from Bristol Myers Squibb.

  3. IMA Acquires Isolator Equipment Provider Prosys Sampling Systems Limited 4/1/2026

    The IMA Group strengthens its presence in aseptic and containment isolator technology. IMA has recently signed with ProSys Sampling Systems Limited an agreement that provides for the purchase of a majority of the company’s shares. Established in 1997, ProSys is a leading provider of Isolator and Sampling equipment to the global bio-pharmaceutical market.

  4. Samsung Biologics Completes Acquisition Of GSK's Manufacturing Facility In Rockville, Maryland 3/31/2026

    Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States.

  5. PSC Biotech Partners With UVD Robots To Bring Autonomous UV-C Disinfection Technology To Drug Manufacturing 3/26/2026

    PSC Biotech is proud to partner with UVD Robots, part of Blue Ocean Robotics, to bring autonomous UV-C disinfection technology to pharmaceutical and life sciences facilities across the United States, Australia, and Singapore.

  6. TerraPower Isotopes Announces Plans To Build New cGMP Drug Manufacturing Facility In Philadelphia 3/23/2026

    TerraPower Isotopes® (TPI®) announced today that the company is building its flagship current Good Manufacturing Practices (cGMP) actinium-225 (ac-225) manufacturing facility in the Bellwether District of Philadelphia, Pennsylvania.

  7. Experience Safer Pharmaceutical Processing With Esco Lifesciences At INTERPHEX 2026 3/20/2026
  8. Discover Safer, Smarter Pharmaceutical Processing With Esco Lifesciences 3/20/2026
  9. Axplora Announces $60 Million High Potency API Manufacturing Facility Expansion In Italy 3/17/2026

    Axplora, a global leader in complex active pharmaceutical ingredient (API) manufacturing, today announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli. The latest phase includes construction of a new 4,500 m², three-storey R&D and laboratory hub, designed to accelerate development, expand execution capacity and deliver cost-efficient high-potency manufacturing at scale.

  10. METTLER TOLEDO Launches New eGuide To Help Food Manufacturers Prevent Physical Contamination 3/17/2026